Market Research Logo

Slovakia Pharmaceuticals and Healthcare Report Q2 2016

Slovakia Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Improving domestic economic outlook will provide a boost to healthcare expenditure inSlovakia in the short term. Over the longer term, we expect healthcare spending to accelerate, givenSlovakia's ageing population and burden of chronic diseases. With public finances on a firmer footing and acentre-left government promising more generous social spending, multinational drugmakers and medicaldevice companies can expect to see growth in revenues from Slovakia.

Headline Expenditure Projections

Pharmaceuticals: EUR1.91bn (USD2.10bn) in 2015 to EUR1.97bn (USD2.12bn) in 2016; +2.8% inlocal currency terms and +0.6% in US dollar terms. Forecast revised slightly downwards from lastquarter.

Healthcare: EUR6.27bn (USD6.89bn) in 2015 to EUR6.45bn (USD6.94bn) in 2016; +2.9% in localcurrency terms and +0.7% in US dollar terms. Forecast revised slightly downwards from last quarter.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Slovakia 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Slovakia 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Slovakia 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Slovakia 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Slovakia 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Slovakia 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Slovakia 2012-2020)
Generic Drug Market Forecast
Table: Members Of GENAS, 2015
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Slovakia 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Slovakia 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Slovakia 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Slovakia 2014-2020)
Industry Risk/Reward Index
Central And Eastern Europe Risk/Reward Index
Slovakia Risk/Reward Index
Rewards
Risks
Regulatory Review
Regulatory Regime
Intellectual Property Issues
Pricing Regime
Table: Indexed Price Build-Up For Prescription And Non-Prescription Medicines In Slovakia
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Healthcare Resources (Slovakia 2010-2015)
Table: Healthcare Personnel (Slovakia 2010-2015)
Table: Healthcare Activity (Slovakia 2010-2015)
Research And Development
Table: Members Of BITCET, 2011
Table: Members Of SLOVBIOTECH, 2010
Clinical Trials
Epidemiology
Table: Main Causes Of Mortality And Morbidity In Slovakia
Competitive Landscape
Research-Based Industry
Table: Members Of SAFS, 2012
Table: Multinational Market Activity
Generic Drugmakers
Table: Registered Pharmaceutical Manufacturers
Pharmaceutical Distribution
Table: ADL Members, 2012 (Manufacturers, unless otherwise indicated)
Pharmaceutical Retail Sector
Company Profile
Biotika
HBM Pharma
Imuna Pharma
Demographic Forecast
Table: Population Headline Indicators (Slovakia 1990-2025)
Table: Key Population Ratios (Slovakia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Slovakia 1990-2025)
Table: Population By Age Group (Slovakia 1990-2025)
Table: Population By Age Group % (Slovakia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report